Brian Budke

1.1k total citations
17 papers, 825 citations indexed

About

Brian Budke is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Brian Budke has authored 17 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Genetics. Recurrent topics in Brian Budke's work include DNA Repair Mechanisms (14 papers), Cancer therapeutics and mechanisms (6 papers) and PARP inhibition in cancer therapy (6 papers). Brian Budke is often cited by papers focused on DNA Repair Mechanisms (14 papers), Cancer therapeutics and mechanisms (6 papers) and PARP inhibition in cancer therapy (6 papers). Brian Budke collaborates with scholars based in United States, France and Switzerland. Brian Budke's co-authors include Douglas K. Bishop, Philip P. Connell, Jennifer Grubb, Alan P. Kozikowski, Yuen‐Ling Chan, Cloud Veronica, Hillary L. Logan, Jay H. Kalin, Michał Pawłowski and Andrei Kuzminov and has published in prestigious journals such as Science, Nucleic Acids Research and Cancer Research.

In The Last Decade

Brian Budke

17 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Budke United States	13	707	250	103	72	70	17	825
Jun Hyun Kim United States	16	616 0.9×	199 0.8×	68 0.7×	140 1.9×	60 0.9×	27	861
Takahiko Seki Japan	15	558 0.8×	182 0.7×	96 0.9×	50 0.7×	48 0.7×	27	670
Sung‐Bau Lee Taiwan	13	599 0.8×	205 0.8×	57 0.6×	35 0.5×	52 0.7×	25	727
Jody M. Havener United States	10	699 1.0×	207 0.8×	122 1.2×	50 0.7×	81 1.2×	12	743
Kenjiro Asagoshi Japan	17	952 1.3×	182 0.7×	233 2.3×	70 1.0×	87 1.2×	24	1.1k
Ozan Aygün United States	10	750 1.1×	112 0.4×	100 1.0×	101 1.4×	72 1.0×	12	882
Kostya I. Panov United Kingdom	19	1.1k 1.6×	121 0.5×	89 0.9×	38 0.5×	91 1.3×	32	1.2k
Tomás Aparicio United States	10	737 1.0×	176 0.7×	98 1.0×	60 0.8×	87 1.2×	11	870
Kayoko Nishi United States	17	609 0.9×	147 0.6×	70 0.7×	33 0.5×	98 1.4×	26	726
Aaron Patrick United States	11	510 0.7×	174 0.7×	98 1.0×	30 0.4×	65 0.9×	16	652

Countries citing papers authored by Brian Budke

Since Specialization

Citations

This map shows the geographic impact of Brian Budke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Budke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Budke more than expected).

Fields of papers citing papers by Brian Budke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Budke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Budke. The network helps show where Brian Budke may publish in the future.

Co-authorship network of co-authors of Brian Budke

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Budke. A scholar is included among the top collaborators of Brian Budke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Budke. Brian Budke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Budke, Brian, et al.. (2022). Noncanonical NF-κB factor p100/p52 regulates homologous recombination and modulates sensitivity to DNA-damaging therapy. Nucleic Acids Research. 50(11). 6251–6263. 7 indexed citations

Chlenski, Alexandre, Chanyoung Park, Helen R. Salwen, et al.. (2019). Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. Molecular Cancer Therapeutics. 18(3). 507–516. 20 indexed citations

Budke, Brian, et al.. (2019). Optimization of Drug Candidates That Inhibit the D‐Loop Activity of RAD51. ChemMedChem. 14(10). 1031–1040. 16 indexed citations

Budke, Brian, Wei Lv, Alan P. Kozikowski, & Philip P. Connell. (2016). Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?. ChemMedChem. 11(22). 2468–2473. 35 indexed citations

Lv, Wei, Brian Budke, Michał Pawłowski, Philip P. Connell, & Alan P. Kozikowski. (2016). Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. Journal of Medicinal Chemistry. 59(10). 4511–4525. 46 indexed citations

Lv, Wei, Brian Budke, Alan P. Kozikowski, & Philip P. Connell. (2016). Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. International Journal of Radiation Oncology*Biology*Physics. 96(2). S16–S17. 2 indexed citations

Thierry, Sylvain, Ludivine Sinzelle, Christina Calmels, et al.. (2015). Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration. Chemistry & Biology. 22(6). 712–723. 9 indexed citations

Mason, Jennifer M., William D. Wright, Jennifer Grubb, et al.. (2015). RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells. Nucleic Acids Research. 43(6). 3180–3196. 58 indexed citations

Mason, Jennifer M., Hillary L. Logan, Brian Budke, et al.. (2014). The RAD51-Stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors. Cancer Research. 74(13). 3546–3555. 41 indexed citations

10.

Pitroda, Sean P., Itai Pashtan, Hillary L. Logan, et al.. (2014). DNA Repair Pathway Gene Expression Score Correlates with Repair Proficiency and Tumor Sensitivity to Chemotherapy. Science Translational Medicine. 6(229). 229ra42–229ra42. 67 indexed citations

11.

Budke, Brian, Yuen‐Ling Chan, Douglas K. Bishop, & Philip P. Connell. (2013). Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealing. Nucleic Acids Research. 41(13). e130–e130. 12 indexed citations

12.

Veronica, Cloud, Yuen‐Ling Chan, Jennifer Grubb, Brian Budke, & Douglas K. Bishop. (2012). Rad51 Is an Accessory Factor for Dmc1-Mediated Joint Molecule Formation During Meiosis. Science. 337(6099). 1222–1225. 241 indexed citations

13.

Budke, Brian, Jay H. Kalin, Michał Pawłowski, et al.. (2012). An Optimized RAD51 Inhibitor That Disrupts Homologous Recombination without Requiring Michael Acceptor Reactivity. Journal of Medicinal Chemistry. 56(1). 254–263. 80 indexed citations

14.

Budke, Brian, Hillary L. Logan, Jay H. Kalin, et al.. (2012). RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Research. 40(15). 7347–7357. 143 indexed citations

15.

Budke, Brian & Andrei Kuzminov. (2009). Production of clastogenic DNA precursors by the nucleotide metabolism inEscherichia coli. Molecular Microbiology. 75(1). 230–245. 21 indexed citations

16.

Budke, Brian & Andrei Kuzminov. (2006). Hypoxanthine Incorporation Is Nonmutagenic in Escherichia coli. Journal of Bacteriology. 188(18). 6553–6560. 25 indexed citations

17.

Christiansen, James L., et al.. (2001). A final report of the Hayflick limit in reptiles, a test of potential immortality. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact